Towa Pharmaceutical Co., Ltd. (TYO:4553)

Towa Pharmaceutical Revenue

Towa Pharmaceutical had revenue of 70.87B JPY in the quarter ending September 30, 2026, with 8.49% growth. This brings the company's total for the last twelve months to 285.49B, up 7.06% year-over-year. In the fiscal year ending March 31, 2026, Towa Pharmaceutical had annual revenue of 273.71B with 5.44% growth. That makes Towa Pharmaceutical the 5,395th largest company in the world by revenue and 555th in Japan.

• Revenue (ttm): 285.49B
• Revenue Growth: +7.06%
• P/S Ratio: 0.58
• Revenue / Employee: 57.99M
• Employees: 4,923
• Market Cap: 164.70B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Domestic 216.98B 79.0%
• Overseas 57.63B 21.0%

By Geography

Chart

• Japan 206.32B 75.4%
• Overseas 67.39B 24.6%

Fiscal year ended Mar 31, 2026 See the full Towa Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	273.71B	14.12B	5.44%
Mar 31, 2025	259.59B	31.66B	13.89%
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%

Data Source: S&P Global Market Intelligence Last updated: Nov 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error